How does ginsenoside Rh2 reduce the risk of ovarian cancer recurrence?

< ="- "> If you want to reduce the recurrence of ovarian cancer, you must know why ovarian cancer recurs. In this regard, we invited Chief Physician Huang Pei, a well-known cancer prevention expert, to give us the following answers.
<> To reduce the recurrence of ovarian cancer, the lesions must be completely removed <> During ovarian cancer surgery, the primary tumor and visible pelvic and abdominal metastases should be removed as much as possible or the diameter of the residual cancer should be smaller than . ~.㎝. For epithelial cancer, the omentum and appendix must also be removed. <> The management of intestinal metastasis is an important part of ovarian cancer surgery and one of the determinants of prognosis. Cancer masses with shallow infiltration can be removed by surgery, while those with larger tumors or deeper infiltration cannot be tolerated and should undergo intestinal resection and total anastomosis. The most intestinal metastasis or involvement is in the transverse colon, sigmoid colon and rectum. If there is still rectum left after resection of the sigmoid colon and rectum, an anastomosis should be performed as much as possible. If anastomosis is difficult or the tissue at the broken end is unhealthy, a colostomy must be performed. The intestinal stapler can be used to complete end-to-end or end-to-side anastomosis during low rectal resection, which is fast, effective and avoids the pain of fistula. Small implanted nodules in the liver, spleen and diaphragm generally do not need to be removed, but large cancer masses that rely on chemotherapy should be removed with great effort. The lymphatic metastasis rate of ovarian cancer is as high as over %. Currently, most experience has shown that lymph node dissection should be used as a component of cytoreductive surgery. For those who can remove the primary and secondary lesions, it is more beneficial to remove the retroperitoneal lymph nodes. If the primary tumor or metastasis cannot achieve cytoreduction, forced lymph node removal will not be beneficial. <> To reduce the recurrence of ovarian cancer, long-term chemotherapy must be adhered to <> Chemotherapy for ovarian cancer should be long-term and continuous, especially for patients with advanced stage and those who cannot be removed by surgery. The medication plan is one course of treatment per month in the first year after surgery, one course of treatment per month in the second year, one course of treatment per month in the second year, and one course of treatment per month in the first year, and then switch to oral medication. <> Depending on the clinical stage, tissue differentiation, completeness of surgical resection, patient response, etc., the drug can be discontinued if there are no signs of recurrence after 10 years. Try to avoid stopping chemotherapy midway. Stopping chemotherapy midway can increase the possibility of recurrence of ovarian malignant tumors. <> Reducing the recurrence of ovarian cancer requires adjuvant treatment with traditional Chinese medicine <> Clinical treatment of ovarian cancer recurrence advocates systemic comprehensive treatment with traditional Chinese medicine. For primary ovarian cancer lesions, if the patient can tolerate surgery, palliative resection can be performed first and then supplemented with radiotherapy, chemotherapy and ginsenoside R treatment. Lesions that have metastasized to the liver can be resected at the same time as the primary ovarian cancer lesion. For patients with ovarian cancer metastasis who are weak and unable to tolerate surgery, combined radiotherapy and chemotherapy + traditional Chinese medicine are often used in clinical treatment. <> It is worth mentioning the role of ginsenoside R in the treatment of ovarian cancer metastasis. Disease in any part of the body is not just a local problem, it is extremely closely related to a person's overall immune status. Among the cancer treatment methods of Western medicine, surgery, radiotherapy or intervention are local treatments, chemotherapy and immunotherapy are systemic treatments, but most of them are damaging treatments with too many side effects and cannot adjust the functions of various organs. The therapeutic advantage of ginsenoside R is obvious. It can not only adjust the functions of various organs, but also provide local treatment to eliminate evil without damaging the body. Ginsenoside R combined with surgery, radiotherapy and chemotherapy can be used in the treatment of recurrence of ovarian cancer. On the one hand, it can enhance the inhibitory effect on tumors, and on the other hand, it can reduce the damage caused by Western medicine treatment to the human body, enhance the patient's immunity and speed up the recovery of body functions. <> Ginsenoside r manufacturer Consultant Hu’s hourly consultation hotline (Consultant Hu) <> For more cancer rehabilitation consultation contact, you can also contact us through your mobile phone number or directly add WeChat consultation